Mike Pence on Leadership and the Future of the Republican Party
Former US Vice President Mike Pence looks back on the events of January 6 2021, his final days in office with President Trump and his…
Thought Leader: Mike Pence
Access For 21st Century Cures: Updating Medicare’s Approach To Coverage And Payment
By Scott Gottlieb (original source Health Affairs)
“In recent years, considerable bipartisan Congressional action, leadership from both Democratic and Republican administrations, and broad-based multistakeholder collaborations have focused on improving the tools and regulatory processes at the Food and Drug Administration (FDA), other government agencies, and public-private collaborations to support more efficient and timely development of new medical technologies. Enhanced funding through user fees and the bipartisan Twenty-First Century Cures legislation have supported a robust and better-resourced FDA and enabled science-driven collaborations in a range of areas including innovative clinical trials, “patient-focused” drug development, and greater clarity around standards for regulatory approval of new technologies.”
Click here to read more
Relevant and recent posts
Marc Short on U.S. Investment in Critical Minerals
Why do critical minerals matter now? Marc Short explains how U.S. investment in critical minerals fits into a broader strategy around economic security, manufacturing, and…
Thought Leader: Marc Short
Marc Short on AI Policy and the Government’s Role in Chip Technology Investment
On CNBC, Marc Short breaks down the role of AI policy and how government investment is shaping the future of chip technology. A former Chief…
Thought Leader: Marc Short
More with this speaker
Dr. Scott Gottlieb on Finding Cures for Rare Diseases
Thought Leader: Scott Gottlieb
Dr. Scott Gottlieb: What’s Next for Childhood Vaccines
Thought Leader: Scott Gottlieb
Scott Gottlieb on China’s biotech strategy
Thought Leader: Scott Gottlieb